Table 2.
Interventions to improve screening and follow-up of abnormal screening tests in pediatric primary care, by type of study design
Author, year, design | Condition(s) being screened and screening test(s) | Pre-Intervention or control group screening (%of patients screened, unless otherwise specified) | Post-Intervention or experimental group screening (% of patients screened, unless otherwise specified) | Significance testing (p-value unless otherwise specified) | Nature of the intervention, setting/population, and other comments about the study |
---|---|---|---|---|---|
Randomized Controlled Trials | |||||
1. Margolis PA, et al. (2004) RCT20 |
Lead poisoning, anemia, and tuberculosis: Serum lead level: Intervention Control |
23% 18% |
68% 30% |
<0.05 |
Intervention: Process improvement methods (aka “knowledge translation”) to improve office systems around preventive care services.
Other comments: Data were collected pre- and post-intervention for both control and experimental group practices. Tuberculosis screening was PPD, Mantoux test, or risk assessment |
Hematocrit: Intervention Control |
65% 64% |
79% 71% |
<0.05 | ||
Tuberculosis screening: Intervention Control |
34% 30% |
54% 32% |
<0.05 | ||
2. Minkovitz CS, et al. (2003) RCT35 |
Developmental problems: Parent-reported developmental assessment |
41–43% | 82–84% | <0.001 |
Intervention: Healthy Steps (HS) program a. Co-located developmental specialists to enhance well-child visits; also conducted home visits, provided telephone information line for parents about development, written materials, parent groups, linkages to community resources Setting/population: 15 practices randomized in 14 states; experimental n=2021 patients, control n=1716 patients; post-intervention data were collected for children aged 30–33 months. Other comments: Parents reported any developmental screening questions (not specifically whether a formal tool was used) |
3. Scholes D, et al. (2006) RCT27 |
Chlamydia infection: Urine Chlamydia screening |
Practice-level intervention: 37.5% | 39.6% | 0.31 |
Intervention: Practice and patient-level interventions
|
EMR reminder: 40.8% | 42.6% | 0.27 | |||
4. Shafer MA, et al. (2002) RCT23 |
Chlamydia infection: Urine Chlamydia screening |
21% | 65% | <0.001 |
Intervention: Quality improvement initiative within managed care network
|
5. Tebb KP, et al. (2009) RCT29 |
Chlamydia infection: Urine Chlamydia screening Intervention Control |
26% 32% |
42% 30% |
<0.001 |
Intervention: Quality improvement initiative within managed care network
Other comments: Data were collected pre- and post-intervention for both control and experimental group practices. |
Pre-post intervention design | |||||
6. Adams WG et al. (2003) Pre-post37 |
Developmental problems, anemia, lead poisoning, hearing and vision problems: Language development |
65.1% | 70.0% |
Relative risk (95% confidence interval): 1.07 (0.97–1.09) |
Intervention: EMR template with prompts to improve preventive care services
Other comments: Pre-intervention group had paper charts with well-child visit templates; sample for specific tests varied because some tests are recommended only for a subset based on age. |
Behavior/social development | 26.4% | 65.7% | 1.16 (1.04–1.28) | ||
Motor development | 63.8% | 73.9% | 2.49 (2.00–3.10) | ||
Hematocrit | 82.5% | 85.3% | 1.03 (0.91–1.17) | ||
Serum lead level | 66.7% | 79.1% | 1.19 (0.99–1.43) | ||
Vision | 42.9% | 50.0% | 1.17 (0.80–1.70) | ||
Hearing | 33.3% | 48.3% | 1.45 (0.92–2.28) | ||
7. Applegate H, et al. (2003) Pre-post33 |
Behavior, developmental and emotional problems: Discussion about behavior, developmental or emotional problems (# items discussed per visit) |
1.6 items | 10.4 items per visit after Stage 1; 9.9 items per visit after Stage 2 |
Intervention: Provider education and support tools to implement Pediatric Symptom Checklist (PSC); intervention was 2 stages
Other comments: No significance testing reported |
|
Intervention for behavior and emotional problems (# of interventions per visit) | 0 interventions | 0.125 interventions per visit after Stage 1; 1.9 interventions per visit after Stage 2 | |||
8. Block B, et al. (1996) Pre-post40 |
Follow up of elevated lead levels: Follow up plan in chart |
32% | 100% |
Intervention: Nurse-led protocol to follow up abnormally elevated lead levels--
Other comments: No significance testing reported |
|
Follow up serum lead level done | 9% | 65% | |||
Parent education about reducing exposure, if persistently high levels | Not measured | 28% | |||
9. Bordley WC, et al. (2001) Pre-post22 |
Anemia, lead poisoning, tuberculosis: Hematocrit |
45% | 67% | 0.001 |
Intervention: Quality improvement intervention to improve preventive care:
Other comments: Lead and tuberculosis screening was risk assessment and laboratory/skin testing, if indicated |
Lead screening | 12% | 48% | 0.001 | ||
Tuberculosis screening | 50% | 52% | NS | ||
10. Dunlop AL, et al. (2007) Pre-post32 |
Obesity: BMI percentile documented in chart |
12% | 15% after Stage 1 28% after Stage 2 |
NS <0.05 |
Intervention: Provider training and support tools for obesity. 2 staged intervention:
|
Nutrition and activity history | 50% | 56% after Stage 1 81% after Stage 2 |
NS <0.05 |
||
Nutrition and activity counseling | 33% | 35% after Stage 1 47% after Stage 2 |
NS <0.05 |
||
11. Lannon CM, et al. (2008) Pre-post21 |
Developmental problems PEDS or ASQ |
30% (received any developmental screening) | 45% (using structured tool (e.g., ASQ)) | NS |
Intervention: Bright Futures Training Intervention Project: learning collaborative/quality improvement initiative to improve preventive care services
Other comments: No participating practices used formal developmental screening tools pre-intervention. |
12. Polacsek M, et al. (2009) Pre-post25 |
Obesity: BMI documented in chart Screening with previsit, self-administered tool to assess patient’s behavior around nutrition and physical activity |
38% Not measured |
94% 82% |
<0.001 <0.001 |
Intervention: Learning collaborative
|
13. Shaw JS, et al. (2006) Pre-post19 |
Lead poisoning, anemia, tuberculosis, hypertension: Lead screening |
72% | 85% | 0.001 |
Interventions: State-wide learning collaborative with 4 1-day learning sessions
Other comments: Tuberculosis and lead screening were risk assessment and laboratory/skin testing, if indicated. |
Hematocrit | 70% | 74% | NS | ||
Vision screening | 62% | 75% | 0.013 | ||
Tuberculosis screening | 18% | 39% | 0.001 | ||
Blood pressure | 85% | 82% | NS | ||
14. Young PC, et al. (2006) Pre-post18 |
Anemia, vision problems, hypertension, obesity: Hematocrit |
49% | 57% | 0.36 |
Intervention: Learning collaborative
|
Vision screening | 46% | 75% | 0.007 | ||
BP screening | 59% | 74% | 0.010 | ||
BMI recorded | 32% | 45% | 0.078 | ||
Post intervention with and without a control group | |||||
15. Gioia PC. (2001) Post intervention without control group38 |
Lead poisoning: Serum lead level |
Not measured | 81% |
Intervention: EMR with point-of-care reminders displayed on screen Population/setting: Single practice in New York; n=208 patients; children born in 1998 |
|
16. Hartmann EE, et al. (2006) Post-intervention without control group34 |
Vision disorders: monocular visual acuity and stereopsis 3 year olds |
Not measured | 70–85% |
Intervention: Vision screening with specific tools for assessing monocular visual acuity and stereopsis.
|
|
4 year olds | Not measured | 93–94% | |||
17. Hull PC, et al. (2008) Post-intervention with concurrent control group39 |
Lead poisoning, anemia, hearing, vision: “Laboratory testing” (serum lead level and hematocrit) |
74% | 100% | <0.001 |
Intervention: Nurse-led protocol
|
Hearing | 12% | 100% | <0.001 | ||
Vision | 23% | 100% | <0.001 | ||
18. Niederman LG, et al. (2007) Post-intervention with concurrent control group36 |
Anemia and lead poisoning: Hematocrit |
77% | 73% | NS |
Intervention: Healthy Steps (HS) program implemented in a resident continuity clinic. Population/setting: One academic practice in Illinois; experimental n=71, control n=192 patients; children aged at least 18 months Other comments: Control group were patients in the practice but not enrolled in HS |
Serum lead level | 64% | 67% | NS | ||
19. Ozer EM, et al. (2005) Post-intervention with concurrent control group31 |
Adolescent health risk behaviors: Adolescent health screening questionnaire |
Not measured | 80% | NA |
Intervention: Provider training, patient questionnaire, and prompts to facilitate communication about adolescent risk behaviors 2 stage intervention:
Other comments: Control practices’ screening did not differ over study period |
Provider asked about alcohol use during visit | 67% | 82% after Stage 1 83% after Stage 2 |
<0.01 <0.001 |
||
Provider counseled on alcohol use during visit | 59% | 77% after Stage 1 81% after Stage 2 |
<0.01 <0.001 |
||
20. Schonwald A, et al. (2009) Post intervention without cuncurrent control group30 |
Behavior and development problems: PEDS |
Not measured | 61% |
Intervention: Implementation of developmental screening using PEDS
Other comments: Use of structured developmental assessments was not routine pre-intervention; authors reported an increase in developmental concerns identified post-intervention (21% vs. 26%, p=0.05); proportion of children referred for developmental concerns did not change post intervention (10% vs 11%). |
|
Time Series | |||||
21. Earls M, et al. (2006) Time series28 |
Developmental problems: ASQ |
24% | 62% at year 2; 76% at year 5 |
Intervention: Quality improvement initiative to improve child development services:
Other comments: No significance testing reported |
|
22. King TM, et al. (2010) Time series24 |
Development problems: PEDS or ASQ |
Not measured | 67% at 1 month; 85% at 9 months |
Intervention: Provider and staff education, physician champion identification
Other comments: Post-intervention screening varied among practices (33–100%); no significance testing reported |
|
23. Pomietto M, et al. (2009) Time series26 |
Obesity: BMI and weight classification documented in chart |
Not measured | 49% at 1 month; 94% at 9 months |
Intervention: Learning collaborative, combined with community and policy-level interventions.
Other comments: No significance testing reported |
Abbreviations:
HS – Healthy Steps
LC – Learning collaborative
BMI – Body mass index
BP – Blood pressure
QI – Quality improvement
HMO – Health maintenance organization
PEDS – Parents’ evaluation of developmental status
EMR – Electronic medical record
EPSDT – Early periodic screening, diagnosis and treatment
ASQ – Ages and stages questionnaire
AAP – American Academy of Pediatrics
RCT – Randomized controlled trial